Clinical Validation of Isothermal Nucleic Acid Amplification Bioassays Modules - GUINEA
Starting soon
Conditions studied: Ebola Hemorrhagic Fever, Lassa Hemorrhagic Fever
In brief
This study aim to validate the clinical performances of two newly developed isothermal nucleic acid amplification bioassays modules for EBOV and LASV. Two retrospective studies will be conducted using biobanked patient samples such as plasma samples and buccal swabs already collected by the Centre de Recherche en Virologie, Laboratoire des Fièvres Hémorragiques Virales de Guinée (CRV-LFHVG) as part of their surveillance and outbreak activities. The diagnostic sensitivity and specificity of the EBOV and LASV bioassays modules will be compared to the gold-standard reverse transcriptase polymerase chain reaction (RT-PCR) technologies used in the national reference lab.
Key facts
- Study ID
- NCT07681752
- Run by
- Institute of Tropical Medicine, Belgium
- People needed
- 150
- Starts
- 2027-01-01
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2026-07-02
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- EBOV and LASV test positive and negative biobanked patient samples
You may not qualify if…
- not applicable
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.